MG01CI extended-release tablet

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
206	脆弱Ｘ症候群	1

206. 脆弱Ｘ症候群

臨床試験数 : 108 / 薬物数 : 91 - (DrugBank : 36) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 77

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02126995 (ClinicalTrials.gov)	June 2014	29/4/2014	A 6-week, Study of MG01CILow Dose and High Dose Compared With Placebo in Adults and Adolescents With ...	A 6-week, Randomized, Multicenter, Double-blind, Parallel, Flexed and Fixed-dose Study of MG01CI(Met ...	Fragile X Syndrome	Drug: MG01CI extended-release tablet	Alcobra Ltd.	NULL	Completed	15 Years	55 Years	Both	62	Phase 2	United States;Israel

First Previous1Next Last